- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Stage IV Prostate Cancer in Australia
Total 313 results
-
Noxopharm LimitedCompletedCancerNew Zealand, Georgia, Australia
-
Novartis PharmaceuticalsRecruitingOligometastatic Prostate Cancer (OMPC)Japan, Singapore, Canada, Israel, Switzerland, Australia, United States
-
Evaxion Biotech A/SMerck Sharp & Dohme LLCRecruitingMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Medical University of ViennaCompleted
-
AstraZenecaRecruitingMetastatic Prostate CancerUnited States, Australia
-
Peter MacCallum Cancer Centre, AustraliaSt Vincent's Hospital, SydneyRecruitingProstate CancerAustralia
-
Evaxion Biotech A/SNovotech (Australia) Pty LimitedTerminatedMelanoma Stage IV | Melanoma Stage IIIAustralia
-
Olivia Newton-John Cancer Research InstituteBristol-Myers Squibb; Barwon Health; Austin Health; Eastern Health; Fiona Stanley... and other collaboratorsRecruitingFollicular Lymphoma Stage II | Follicular Lymphoma Stage III | Follicular Lymphoma Stage IVAustralia
-
BeiGeneTerminatedMetastatic Castration-Resistant Prostate Cancer (mCRPC) | Homologous Recombination Deficiency (HRD)United States, Australia, Puerto Rico, Spain
-
Life Molecular Imaging SATerminatedProstate CancerAustria, Finland
-
Janssen Research & Development, LLCApproved for marketingMetastatic Castration-resistant Prostate CancerBrazil, Austria, Estonia, Israel, Mexico
-
Australian and New Zealand Urogenital and Prostate...Bristol-Myers Squibb; University of Sydney; Advanced Accelerator Applications; Prostate...Active, not recruitingNeoplasms | Urogenital Neoplasms | Neoplasms by Site | Genital Neoplasms, Male | Prostatic Neoplasms | Prostate Cancer | Prostatic DiseaseAustralia
-
AmgenActive, not recruitingNeuroendocrine Prostate CancerBelgium, United States, Austria, Spain, Australia, Netherlands, France, United Kingdom, Japan
-
Atridia Pty Ltd.CompletedProstate Cancer | NeoplasmAustralia
-
Queensland Centre for Gynaecological CancerRoyal Brisbane and Women's Hospital; The University of QueenslandCompletedOvarian Cancer Stage IV | Ovarian Cancer Stage IIIAustralia
-
Telix Pharmaceuticals (Innovations) Pty LimitedActive, not recruiting
-
Yale UniversityNational Cancer Institute (NCI)RecruitingStage IV Prostate Adenocarcinoma AJCC v7United States, Taiwan, Korea, Republic of, Australia, China, Japan
-
St Vincent's Hospital, SydneyClarity Pharmaceuticals LtdCompleted
-
Medical University of GrazTerminatedProstate Cancer | Radiotherapy Side EffectAustria
-
Pellficure Pharmaceuticals, IncTerminatedProstate CancerUnited States, Australia
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, Australia; Novartis Pharmaceuticals and other collaboratorsCompletedProstate CancerAustralia, New Zealand
-
Nuvation Bio Inc.RecruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Breast Carcinoma | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Cancer of the Ovary | Pancreas Cancer | Triple-negative Breast Cancer | Cancer of Pancreas | Pancreas Neoplasm | Prostate Neoplasm | Cancer... and other conditionsUnited States, Australia
-
Royal North Shore HospitalRecruitingProstate CancerAustralia
-
Western Sydney Local Health DistrictUniversity of Western SydneyRecruitingHepatitis | Lung Cancer, Non-small Cell | Lung Cancer Stage IVAustralia
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate CancerUnited States, Canada, France, Spain, United Kingdom, Australia, Poland, Germany, Austria, Belgium, Netherlands, Italy, Chile, South Africa, Argentina
-
Melanoma and Skin Cancer Trials LimitedBristol-Myers Squibb; Amgen; Peter MacCallum Cancer Centre, AustraliaActive, not recruitingMelanoma | Melanoma Stage Iv | Melanoma Stage IiiAustralia
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Medical University of ViennaWithdrawnProstate CancerAustria
-
Life Molecular Imaging SACompleted
-
Janssen Research & Development, LLCCompletedMetastatic Breast Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Spain, Germany, Sweden, Australia, United Kingdom
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
EMD SeronoCompletedProstate Cancer MetastaticUnited States, Australia, France, Poland, Russian Federation, Spain, Germany, Netherlands, Slovakia, Canada, South Africa, Belgium
-
Peter MacCallum Cancer Centre, AustraliaUnknownProstate CancerAustralia, New Zealand
-
Aptevo TherapeuticsCompletedProstate CancerUnited States, Australia
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Pancreas | Recurrent Pancreatic Cancer | Stage IV Pancreatic CancerUnited States, Singapore, Australia
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
AstraZenecaCompletedNon-Metastatic Prostate CancerCzech Republic, Italy, South Africa, United Kingdom, Germany, Poland, Netherlands, Austria, Belgium, Hungary, Israel, Portugal, Mexico, Spain, Australia, Ireland
-
St Vincent's Hospital, SydneyCompleted
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Astellas Pharma IncAstellas Pharma US, Inc.TerminatedProstatic Neoplasms | Hormone-Refractory Prostate CancerUnited States, Ireland, Australia, France, United Kingdom, Belgium, Germany, Netherlands, Poland, Spain
-
AstraZenecaBayerRecruitingMetastatic Prostate CancerItaly, United Kingdom, Australia, United States
-
Medical University of ViennaBSM Diagnostica GmbH Vienna; Siemens Healthcare GmbHCompleted
-
Lawson Health Research InstituteCompletedProstate CancerUnited Kingdom, Australia, Canada
-
Bavarian NordicCompletedProstate Cancer MetastaticUnited States, Spain, Germany, Netherlands, Belgium, United Kingdom, Australia, Denmark, France, Canada, Israel, Russian Federation, Puerto Rico, Estonia, Poland, Iceland
-
Trans Tasman Radiation Oncology GroupAustralian and New Zealand Urogenital and Prostate Cancer Trials Group; Urological...Active, not recruiting
-
ExelixisTerminatedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerUnited States, Canada, Australia, United Kingdom, Ireland